Search

Search Results
Results 3971 - 3980 of 5284 for Active site
  • News - 22 Mar 2004
    A clinical study comparing three treatments of type 2 diabetes in children and teens has begun in 12 medical centers and their affiliated sites around the country, HHS Secretary Tommy G. Thompson...
  • News - 22 Mar 2004
    International research teams studying two distinct populations have found variants in a gene that may predispose people to type 2 diabetes, the most common form of the disease. The researchers, who...
  • Drug - 10 Jun 2026
    Consumer Medicine Information (CMI) about Resonium A intended for persons living in Australia.
  • News - 8 Jun 2026
    Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and...
  • Drug - 4 Jun 2026
    Consumer Medicine Information (CMI) about Thymoglobuline intended for persons living in Australia.
  • Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Sabril intended for persons living in Australia.
  • Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Wezlana intended for persons living in Australia.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Rifadin Oral intended for persons living in Australia.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Rifadin Injection intended for persons living in Australia.
  • News - 29 May 2026
    Researchers mapped more than 11,000 transcriptomes across mice, rats, macaques, and humans, revealing conserved molecular signatures of aging and mortality across tissues, species, and cell types. The...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.